Sees FY26 comparable sales growth 3%-4.5%. Sees FY26 free cash flow EUR 1.3B-1.5B. The company said, “Within the context of an uncertain macro-environment, Philips (PHG)’ 2026 outlook includes currently known tariffs. It excludes ongoing Philips Respironics-related proceedings, including the investigation by the US Department of Justice.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- Koninklijke Philips N.V. (PHG) Q4 Earnings Cheat Sheet
- Emergency Care Holdings acquires Philips Emergency Care business
- Philips: Limited Margin Upside and Balanced Risk-Reward Support Neutral (Hold) Rating
- Philips price target raised to EUR 25 from EUR 23 at Citi
- Philips initiated with a Sector Perform at RBC Capital